---
title: "TRex Bio surges 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/304662326.md"
description: "TRex Bio rose 8.08% to US$14.04. The intraday swing reached 10.16%."
datetime: "2026-11-06T15:14:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/304662326.md)
  - [en](https://longbridge.com/en/news/304662326.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/304662326.md)
generator: "portal-rs"
---

# TRex Bio surges 8%

TRex Bio (TRXB.US) surged more than **8%** during regular trading to **$14.04**.

The intraday swing reached 10.16%.

The Nasdaq Composite is down 2.66% over the past five sessions and up 6.53% year to date.

Stifel initiated coverage with a Buy rating and a price target of $39, while JPMorgan also started coverage on the same day with an Overweight rating and a $20 price target.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [TRXB.US](https://longbridge.com/en/quote/TRXB.US.md)

## Related News & Research

- [TRXB’s TRB-061 Drives Analyst Confidence as the $20 Price Target Remains Unchanged](https://longbridge.com/en/news/305821317.md)
- [Major Investor Makes Bold New Move into TRex Bio Stock](https://longbridge.com/en/news/301782322.md)
- [Is ServiceNow (NOW) Trading At Too High A Premium For Earnings?](https://longbridge.com/en/news/306039339.md)
- [Alibaba Q2 revenue rises on AI Cloud and Compute Services strength](https://longbridge.com/en/news/306100634.md)
- [How did Coinbase stop deepfake Elon Musk’s promise to double your crypto?](https://longbridge.com/en/news/306049317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**